Evidence map›Paper›PMID 19945543›Full record

ReviewThe international journal of biochemistry & cell biology2010

Crosstalk between the DNA damage response, histone modifications and neovascularisation.

Athanassios Vassilopoulos, Chu-Xia Deng, Triantafyllos Chavakis

Open access · greenAbstract readReview
In one paragraph

Review in The international journal of biochemistry & cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer.European journal of human genetics : EJHG · 2013
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Athanassios VassilopoulosGenetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Chu-Xia Deng
Triantafyllos Chavakis
National Institutes of Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Chemoprevention and therapeutic treatment of BRCA1 associated mammary tumorsZIADK056009 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI DENG, CHUXIA · 2009 to 2014
$4.0M
Roles of BRCA1 transcription target genes in tumorigenesis and agingZIADK056011 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI DENG, CHUXIA · 2009 to 2014
$3.9M
Crosstalk Between Inflammation and AngiogenesisZIABC010664 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHAVAKIS, TRIANTAFYLLOS · 2009 to 2010
$592k
Intramural NIH HHS ZIA BC010664
6 · The paper itself

Abstract

Neovascularisation is critical in several malignant and inflammatory conditions, as well as in the course of eye disorders. During new vessel formation, endothelial cell functions, such as proliferation and sprouting are very important and are regulated by a variety of growth factors. The DNA damage response machinery as well as factors regulating histone modifications, such as histone deacetylases, regulate cell fate as well as gene expression. Recent evidence has pointed to potential interactions among BRCA1, H2AX and SIRT1 in these intracellular pathways and neovascularisation, which will be reviewed here.

Indexed as

DNA DamageNeovascularization, PhysiologicAnimalsBRCA1 ProteinHistonesHumansSirtuinsBRCA1 ProteinHistonesSirtuins

Identifiers

PMID19945543
PMCPMC2818768
OpenAlexW2090296094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.